Citation: Jp. Duffy et al., COMBINATION OF SPECIFIC HISTOCHEMICAL STAINING OF EOSINOPHILS AND MAST-CELLS WITH IMMUNOHISTOCHEMICAL DEMONSTRATION OF NEURAL ANTIGENS, Journal of histotechnology, 21(1), 1998, pp. 29-31
Citation: Sj. Darnton et K. Jenner, MICROWAVE IRRADIATION LOWERS IMMUNOHISTOLOGICAL DETECTION THRESHOLDS FOR P53 PROTEIN IN SQUAMOUS EPITHELIUM FROM NONNEOPLASTIC ESOPHAGUS, Journal of pathology, 185(3), 1998, pp. 334-335
Authors:
COATESWORTH AP
DARNTON SJ
GREEN RM
CAYTON RM
ANTONAKOPOULOS GN
Citation: Ap. Coatesworth et al., A CASE OF SYSTEMIC PSEUDO-PSEUDOXANTHOMA ELASTICUM WITH DIVERSE SYMPTOMATOLOGY CAUSED BY LONG-TERM PENICILLAMINE USE, Journal of Clinical Pathology, 51(2), 1998, pp. 169-171
Authors:
SANDERS DSA
BRUTON R
DARNTON SJ
CASSON AG
HANSON I
WILLIAMS HK
JANKOWSKI J
Citation: Dsa. Sanders et al., SEQUENTIAL-CHANGES IN CADHERIN-CATENIN EXPRESSION ASSOCIATED WITH THEPROGRESSION AND HETEROGENEITY OF PRIMARY ESOPHAGEAL SQUAMOUS CARCINOMA, International journal of cancer, 79(6), 1998, pp. 573-579
Authors:
JENNER K
DARNTON SJ
MORRIS AG
MATTHEWS HR
Citation: K. Jenner et al., HUMAN-PAPILLOMAVIRUS AND P53 IN ESOPHAGEAL SQUAMOUS CARCINOMA AN NONMALIGNANT ESOPHAGUS, Journal of pathology, 182, 1997, pp. 31-31
Authors:
JIAN WG
DARNTON SJ
JENNER K
BILLINGHAM L
MATTHEWS HR
Citation: Wg. Jian et al., EXPRESSION OF E-CADHERIN IN ESOPHAGEAL-CARCINOMA FROM THE UK AND CHINA - DISPARITIES IN PROGNOSTIC-SIGNIFICANCE, Journal of pathology, 181, 1997, pp. 15-15
Citation: Eg. Jian et al., EXPRESSION OF E-CADHERIN IN ESOPHAGEAL CARCINOMAS FROM THE UK AND CHINA - DISPARITIES IN PROGNOSTIC-SIGNIFICANCE, Journal of Clinical Pathology, 50(8), 1997, pp. 640-644
Authors:
ROCKETT JC
LARKIN K
DARNTON SJ
MORRIS AG
MATTHEWS HR
Citation: Jc. Rockett et al., 5 NEWLY ESTABLISHED ESOPHAGEAL-CARCINOMA CELL-LINES - PHENOTYPIC AND IMMUNOLOGICAL CHARACTERIZATION, British Journal of Cancer, 75(2), 1997, pp. 258-263
Authors:
JENNER K
DARNTON SJ
BILLINGHAM L
WARFIELD AT
MATTHEWS HR
Citation: K. Jenner et al., TUMOR HETEROGENEITY - A PROBLEM IN BIOPSY ASSESSMENT OF THE PROLIFERATION INDEX OF ESOPHAGEAL ADENOCARCINOMAS, JCP. Clinical molecular pathology, 49(1), 1996, pp. 61-63
Authors:
ALLEN SM
DUFFY JP
DARNTON SJ
MATTHEWS HR
CULLEN MH
Citation: Sm. Allen et al., PHASE-II STUDY OF MITOMYCIN, IFOSFAMIDE AND CISPLATIN IN ADENOCARCINOMA OF THE ESOPHAGUS, Cancer chemotherapy and pharmacology, 37(5), 1996, pp. 496-498
Citation: Jc. Rockett et al., LYMPHOCYTE INFILTRATION IN ESOPHAGEAL-CARCINOMA - LACK OF CORRELATIONWITH MHC ANTIGENS, ICAM-1, AND TUMOR STAGE AND GRADE, Journal of Clinical Pathology, 49(3), 1996, pp. 264-267
Citation: Jc. Rockett et al., EXPRESSION OF HLA-ABC, HLA-DR AND INTERCELLULAR-ADHESION MOLECULE-1 IN ESOPHAGEAL-CARCINOMA, Journal of Clinical Pathology, 48(6), 1995, pp. 539-544
Authors:
DARNTON SJ
JENNER K
STEYN RS
FERRY DR
MATTHEWS HR
Citation: Sj. Darnton et al., LACK OF CORRELATION OF P-GLYCOPROTEIN EXPRESSION WITH RESPONSE TO MICCHEMOTHERAPY IN ESOPHAGEAL CANCER, Journal of Clinical Pathology, 48(11), 1995, pp. 1064-1066
Citation: Gn. Antonakopoulos et al., EFFECTS OF CHEMOTHERAPY ON ULTRASTRUCTURE OF ESOPHAGEAL SQUAMOUS-CELLCARCINOMA, Histopathology, 25(5), 1994, pp. 447-454
Authors:
VIJEYASINGAM R
DARNTON SJ
JENNER K
ALLEN CA
BILLINGHAM C
MATTHEWS HR
Citation: R. Vijeyasingam et al., EXPRESSION OF P53 PROTEIN IN ESOPHAGEAL-CARCINOMA - CLINICOPATHOLOGICAL CORRELATION AND PROGNOSTIC-SIGNIFICANCE, British Journal of Surgery, 81(11), 1994, pp. 1623-1626